FedEx offers new solution for deep frozen shipments

Published: 28-Jan-2011
Logistics

The solution has benefits for suppliers of clinical trials, diagnostics, biotech or pharma products


Fedex Corp has launched a FedEx Deep Frozen Shipping Solution for the shipping of temperature-sensitive healthcare products around the world.

The solution uses liquid nitrogen dry vapour technology that maintains a temperature of below -150 °C for up to 10 days using the CryoPort Express Dry Shipper. Unlike dry ice, this technology is classified as non-hazardous, which eliminates the complexities associated with being classified as dangerous goods.

In addition, the overall process is said to be simple. Customers place orders online through a customised FedEx portal. FedEx provides the pre-conditioned container to the customer to load their temperature-sensitive product. FedEx then delivers the container to its final destination while actively monitoring the shipment and intervening if needed during transit. Finally, it picks up the container and returns it for refurbishing.

‘The FedEx Deep Frozen Shipping Solution combines innovative dry vapour technology with the reliability of FedEx logistics management to provide customers with the highest level of integrity and security for their high-value frozen shipments worldwide,’ said Raj Subramaniam, senior vice president of Global Marketing for FedEx.

Customers involved with clinical trials, diagnostics, biotechnology or manufacturing of pharmaceuticals could benefit from the solution. The FedEx Deep Frozen Shipping Solution is classified under the International Air Transport Association (IATA) as a non-hazardous dry shipper and meets the requirements to handle both infectious substances (UN3373) and non-infectious clinical samples.

‘We have heard from customers that they want a simpler alternative for shipping temperature-sensitive products that eliminates the complexities involved with dry ice,’ said Carl Asmus, vice president of International Market Development for FedEx.

‘This new service is not only non-hazardous, but it also reduces environmental impact through the use of a recyclable container and liquid nitrogen, which evaporates harmlessly,’ Asmus added.

  • Companies:
  • FedEx Corp
See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Logistics

De-risking an increasingly complex chain

Read more
Pharmaceuticals must reach customers in a timely and effective manner and guidance is increasingly being laid down to ensure sensitive products arrive in perfect condition. Susan Birks highlights the latest logistics trends

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    The pros and cons of distribution agreements For life sciences companies seeking to break into overseas markets, distribution agreements are central to success
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Good pallet practice Are current pallets used for handling and transporting drugs and medicines the best they could be, or is there room for improvement? Jim Hardisty, MD, Goplasticpallets.com, takes a look at how some of the latest pallets are saving the industry time and money
  3. How global air cargo trends are reshaping pharmaceutical transport As we welcome the new decade and the exciting advances it’s expected to unleash, many of the forces that shaped the past decade for transporting pharmaceuticals will continue. Price pressures, alternatives to air freight and increasing automation are just a few. However, there are emerging trends that make 2020 unique
  4. Lessons learned: AstraZeneca’s supply chain resilience during the pandemic With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
  5. Biddle Sawyer

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Logistics

De-risking an increasingly complex chain

Pharmaceuticals must reach customers in a timely and effective manner and guidance is increasingly being laid down to ensure sensitive products arrive in perfect condition. Susan Birks highlights the latest logistics trends
Logistics

FedEx Express offers temperature-sensitive services for healthcare sector

Adds portfolio of service across the EMEA region
Media

A year of challenges and innovation in pharma logistics lies head

Envirotainer CEO, Peter Gisel-Ekdahl, looks to the future and what 2022 holds for pharmaceutical logistics
Packaging

Dachser renews pharma certification in Frankfurt

Drugs and other pharmaceutical products are often temperature-sensitive, urgent shipments that must be handled in compliance with a complex regulatory environment
Pharmaceutical

Lessons learned: AstraZeneca’s supply chain resilience during the pandemic

With 26 manufacturing facilities and a global network of more than 250 suppliers, AstraZeneca’s Global Operations Manufacturing footprint is not only large in scale, it's also highly complex and positioned to deliver medicines to patients worldwide
Digital

The human digital twin: a virtual counterpart to the human worker

Several organisations are familiar with making use of digital twin modelling to improve operations. This digitised model typically enables firms to map the physical characteristics of a production environment as well as its processes. But, this mapping process has limitations because it only includes data from machines and not from humans, which are crucial too
Regulatory

How to comply with regulatory expectations to access compliance data for the entire pharmaceutical supply chain

The pharmaceutical supply chain must work and must be known, is not a novel idea. Anyone involved in this industry’s quality processes knows that mastering 100% of its supply chain has been unachievable in the current state-of-the-art… until now!
Subscribe now